Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 9, 2009, Pages 778-790

  Schneider, Michael F ^a   Bailey, J Elise ^b   Cicero, Theodore J ^c   Dart, Richard C ^b   Inciardi, James A ^d   Parrino, Mark ^e   Muñoz, Alvaro ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF DELAWARE   (United States)

^e American Association for the Treatment of Opioid Dependence   (United States)

Author keywords

Abuse; Maps; Non parametric methods; Prescription opioid analgesics; Signal detection systems

Indexed keywords

BUPRENORPHINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE; TRAMADOL;

ACCURACY; ARTICLE; CLUSTER ANALYSIS; DRUG ABUSE; GEOGRAPHIC DISTRIBUTION; NONPARAMETRIC TEST; POISON CENTER; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRIORITY JOURNAL; RISK MANAGEMENT; SIGNAL DETECTION; SUSTAINED RELEASE FORMULATION; UNITED STATES;

ANALGESICS, OPIOID; DATA COLLECTION; HUMANS; PRESCRIPTION DRUGS; RISK ASSESSMENT; RISK MANAGEMENT; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 70450209157     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1780     Document Type: Article

References (22)

1. Joranson DE, Ryan KM, Gilson AM, et al. Trends in medical use and abuse of opioid analgesics. JAMA 2000; 283: 1710-1714.
2. Zacny J, Bigelow G, Compton P, et al. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend 2003; 69: 215-232. (Pubitemid 36293934)
3. Cicero TJ, Inciardi JA, Muñoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain 2005; 6: 662-672.
4. Government Accounting Office. (GAO) Report to Congressional Requesters. Prescription Drugs: OxyContin abuse and diversion and efforts to address the problem. December2003;GAO-04-0110.
5. Substance Abuse and Mental Health Services Administration. Results from the 2002 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NHSDA Series: H22, DHSS Publication No. SMA 03-3836,2003; Rockville, MD.
6. Substance Abuse and Mental Health Services Administration. Emergency Department. Trends from the Drug Abuse Warning Network, Final Estimates 1995-2002. Office of Applied Studies.2003;NHSDA Series: D-24, DHSS Publication No. SMA 03-3780; Rockville, MD.
7. Cicero TJ, Dart RC, Inciardi JA, et al. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS). Pain Med 2007; 8: 157-170.
8. Cicero TJ, Surratt H, Inciardi JA, et al. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf 2007; 16: 827-840. (Pubitemid 47322580)
9. Smith MY, Schneider MF, Wentz A, et al. Quantifying morbidity associated with the abuse and misuse of opioid analgesics: a comparison of two approaches. Clin Toxicol 2007; 45: 23-30. (Pubitemid 46272656)
10. Rosenblum A, Parrino M, Schnoll SH, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend 2007; 90: 64-71. (Pubitemid 46935374)
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, (4th edn) American Psychiatric Association: Washington, DC, 1994.
12. Inciardi JA, Surratt HL, Lugo Y, et al. The diversion of prescription opioid analgesics. Law Enforcement Executive Forum 2007; 7: 127-141.
13. US Census Bureau. Decennial Census, 2000.
14. Hughes AA, Bogdan GM, Dart RC. Active surveillance of abused and misused prescription opioids using poison center data: a pilot study and descriptive comparison. Clin Toxicol 2007; 45: 144-151.
15. Smith MY, Dart R, Hughes A, et al. Clinician validation of Poison Control Center (PCC) intentional exposure cases involving prescription opioids. Am J Drug Alcohol Abuse 2006; 32: 465-478. (Pubitemid 44231570)
16. Bailey JE, Barton PL, Lezotte D, et al. The effect of FDA approval of a generic competitor to OxyContin (oxycodone HCl controlled-release) tablets on the abuse of oxycodone. Drug Alcohol Depend 2006; 84: 182-187. (Pubitemid 44137460)
17. ZIP. Express. http://www.getzips.com (accessed 1 January 2008).
18. Hollander M, Wolfe DA. Nonparametric Statistical Methods, 2nd Edition. John Wiley & Sons, Inc.: New York, NY, 1999.
19. Smith MY, Irish W, Wang J, Haddox JD, Dart RC. Detecting signals of opioid analgesic abuse: application of a spatial mixed effect Poisson regression model using data from a network of poison control centers. Pharmacoepidemiol Drug Saf 2008; 17: 1050-1059.
20. Substance Abuse Services Commission. OxyContin® abuse: Maine's newest epidemic.2002. Office of Substance Abuse, Maine Department of Behavioral and Developmental Services, Augusta, Maine.
21. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008; 300: 2613-2620.
22. Butler SF, Budman SH, Licari A, et al. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product- specific, public health surveillance system for monitoring prescription drug abuse. Pharmacoepidemiol Drug Saf 2008; 17: 1142-1154.